Press Releases

Archive: October 2021


Contract Update

IXICO plc, the data analytics company delivering insights in neuroscience, announces that it has been notified by a client of an indefinite halt to the client's clinical trial following the receipt of unexpected preclinical data. The client will therefore end its trial while it undertakes additional preclinical studies.

Read more

Trading Update for year ended 30 September 2021

£9. 2 million revenues outperform market expectations EBITDA profitability expected to be materially ahead of market expectations Strong £18. 8 million order book and £6. 7 million cash position. IXICO plc (AIM: IXI), the AI data analytics company delivering insights in neuroscience, announces a trading update for the year ended 30 September 2021.

Read more